[1] ZIMPEL C K,BRANDAO P E,FILHO A F D S,et al.Complete genome sequencing of Mycobacterium bovis SP38 and comparative genomics of Mycobacterium bovis and M.tuberculosis strains[J].Frontiers in Microbiology,2017,8:2389.
[2] WHO.Global tuberculosis report 2017[R].2017.
[3] BRRETT J F,HOCH J A.Two-component signal transduction as a target for microbial anti-infective therapy[J].Antimicrobial Agents & Chemotherapy,1998,42(7):1529-1536.
[4] WHITE M J,HE H,PENOSKE R M,et al.PepD participates in the mycobacterial stress response mediated through MprAB and SigE[J].Journal of Bacteriology,2010,192:1498-1510.
[5] WHITE M J,SAVARYN J P,BRETL D J,et al.The HtrA-like serine protease PepD interacts with and modulates the Mycobacterium tuberculosis 35-kDa antigen outer envelope protein[J].PLoS One,2011,6:e18175.
[6] EWANN F,JACKSON M,PETHE K,et al.Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis[J].Infection and Immunity,2002,70(5):2256-2263.
[7] EWANN F,LOCHT C,SUPPLY P.Intracellular autoregulation of the Mycobacterium tuberculosis PrrA response regulator[J].Journal of Microbiology,2004,150:241-246.
[8] GONZALO-ASENSIO J,MOSTOWY S,HARDERS-WESTERVEEN J,et al.PhoP:A missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence[J].PLoS One,2008,3(10):e3496.
[9] RIFAT D,BISHAI W R,KARAKOUSIS P C.Phosphate depletion:A novel trigger for Mycobacterium tuberculosis persistence[J].Journal of Infectious Diseases,2009,200(7):1126-1135.
[10] LEE H N,JUNG K E,KO I J,et al.Protein-protein interactions between histidine kinases and response regulators of Mycobacterium tuberculosis H37Rv[J].Journal of Microbiology,2012,50(2):270-277.
[11] CANGELOSI G A,DO J S,FREEMAN R,et al.The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium[J].Antimicrob Agents Chemother,2006,50(2):461-468.
[12] GUPTA S,SINHA A,SARKAR D.Transcriptional autoregulation by Mycobacterium tuberculosis PhoP involves recognition of novel direct repeat sequences in the regulatory region of the promoter[J].FEBS Letters,2006,580(22):5328-5338.
[13] GONZALO-ASENSIO J,SOTO C Y,ARBUES A,et al.The Mycobacterium tuberculosis phoPR operon is positively autoregulated in the virulent strain H37Rv[J].Journal of Bacteriology,2008,190:7068-7078.
[14] RAGHAVAN S,P MANZANILLO,CHAN K,et al.Secreted transcription factor controls Mycobacterium tuberculosis virulence[J].Nature,2008,454(7205):717-721.
[15] BAKER J J,JOHNSON B K,ABRAMOVITCH R B.Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources[J].Molecular Microbiology,2014,94(1):56-69.
[16] VIDYARTHI A,KHAN N,AGNIHOTRI T,et al.Antibody response against PhoP efficiently discriminates among healthy individuals,tuberculosis patients and their contacts[J].PLoS One,2017,12(3):e0173769.
[17] WANG L,MIAO X,SOUTHALL N,et al.A high-throughput assay for developing inhibitors of PhoP,a virulence factor of Mycobacterium tuberculosis[J].Combinatorial Chemistry & High Throughput Screening,2016,19(10):855-864.
[18] PATHAK A,GOYAL R,SINHA A,et al.Domain structure of virulence-associated response regulator PhoP of Mycobacterium tuberculosis:Role of the linker region in regulator-promoter interaction(s)[J].Journal of Biological Chemistry,2010,285(45):34309-34318.
[19] MENON S,WANG S.Structure of the response regulator PhoP from Mycobacterium tuberculosis reveals a dimer through the receiver domain[J].Biochemistry,2011,50(26):5948-5957.
[20] MACDONALD R,SRAKAR D,AMER B R,et al.Solution structure of the PhoP DNA-binding domain from Mycobacterium tuberculosis[J].Journal of Biomolecular NMR,2015,63(1):111-117.
[21] WANG S S,JENA E,ISSAR S.Structure of the DNA-binding domain of the response regulator PhoP from Mycobacterium tuberculosis[J].Biochemistry,2007,46(51):14751-14761.
[22] CHESNE-SECK M L,BARILONE N,BOUDUN F,et al.A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra[J].Journal of Bacteriology,2008,190(4):1329-1334.
[23] GOYAL R,DAS A K,SINGH R,et al.Phosphorylation of PhoP protein plays a direct regulatory role in lipid biosynthesis of Mycobacterium tuberculosis[J].Journal of Biological Chemistry,2011,286(52):45197-45208.
[24] ZENG J,CUI T,HE Z G.A genome-wide regulator-DNA interaction network in the human pathogen Mycobacterium tuberculosis H37Rv[J].Journal of Proteome Research,2012,11(9):4682-4692.
[25] SINHA A,GUPTA S,BHUTANI S,et al.PhoP-PhoP interaction at adjacent PhoP binding sites is influenced by protein phosphorylation[J].Journal of Bacteriology,2008,190(4):1317-1328.
[26] HE X,WANG S.DNA consensus sequence motif for binding response regulator PhoP,a virulence regulator of Mycobacterium tuberculosis[J].Biochemistry,2014,53(51):8008-8020.
[27] CIMINO M,THOMAS C,NAMOUCHI A,et al.Identification of DNA binding motifs of the Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system[J].PLoS One,2012,7(8):e42876.
[28] HE X,WANG L,WANG S.Structural basis of DNA sequence recognition by the response regulator PhoP in Mycobacterium tuberculosis[J].Scientific Reports,2016,6(a1):24442.
[29] LUDWICZAK P,GILLERON M,BORDAT Y,et al.Mycobacterium tuberculosis phoP mutant:Lipoarabinomannan molecular structure[J].Microbiology,2002,148(10):3029-3037.
[30] GOUDE R,AMIN A G,CHATTERJEE D,et al.The critical role of embC in Mycobacterium tuberculosis[J].Journal of Bacteriology,2008,190(12):4335-4341.
[31] GOUDE R,PARISH T.The genetics of cell wall biosynthesis in Mycobacterium tuberculosis[J].Future Microbiol,2008,3(3):299-313.
[32] BRENNAN P J.Structure,function,and biogenesis of the cell wall of Mycobacterium tuberculosis[J].Tuberculosis,2003,83:91-97.
[33] WALTERS S B,DUBNAU E,KOLESNIKOVA I,et al.The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis[J].Molecular Microbiology,2006,60(2):312-330.
[34] ASENSIO J G,MAIA C,FERRER N L,et al.The virulence associated two component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis[J].Journal of Biological Chemistry,2006,281(3):1313-1316.
[35] LI A H,WADDELL S J,HINDS J,et al.Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages[J].PLoS One,2010,5(6):e11066.
[36] ABRAMOVITCH R B,ROHDE K H,FONG F H,et al.AprABC:A Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome[J].Molecular Microbiology,2011,80(3):678-694.
[37] JESUS G A,SERGE M,JOSE H W,et al.PhoP:A missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence[J].PLoS One,2008,3(10):e3496.
[38] KUMAR V A,GOYAL R,BANSAL R,et al.EspR-dependent ESAT-6 protein secretion of Mycobacterium tuberculosis requires the presence of virulence regulator PhoP[J].Journal of Biological Chemistry,2016,291(36):19018-19030.
[39] JOHNSON B K,COLVIN C J,NEEDLE D B,et al.The carbonic anhydrase inhibitor ethoxzolamide inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 secretion and attenuates virulence[J].Antimicrobial Agents & Chemotherapy,2015,59(8):4436-4445.
[40] MARTIN C,WILLIAMS A,HERNANDZE-PANDO R,et al.The live Mycobacterium tuberculosis phoP,mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs[J].Vaccine,2006,24(17):3408-3419.
[41] VERRECK F A W,VERVENNE R A W,KONDOVA I,et al.MVA.85A boosting of BCG and an attenuated,phoP deficient Mycobacterium tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques[J].PLoS One,2009,4(4):e5264.
[42] CARDONA P J,ASENSIO J G,ARBUES A,et al.Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant[J].Vaccine,2009,27(18):2499-2505.
[43] ARBUES A,AGUILO J I,GONZALO-ASENSIO J,et al.Construction characterization and preclinical evaluation of MTBVAC,the first live-attenuated Mycobacterium tuberculosis-based vaccine to enter clinical trials[J].Vaccine,2013,31(42):4867-4873. |